Clinical trials
Phase 1/2 Glioblastoma trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2018 | 2 |
| 2020 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Completed | 4 |
| Active, not recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Cancer Research, United Kingdom | 3 |
| Basilea Pharmaceutica | 1 |
| Bayer | 1 |
| Celgene | 1 |
| Forma Therapeutics, Inc. | 1 |
| Incyte Corporation | 1 |
| Medical Research Council | 1 |
| Sapience Therapeutics | 1 |
| Trogenix ltd | 1 |
| Turning Point Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glioblastoma | 12 |
| Carcinoma, Hepatocellular | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Glioma | 2 |
| Lymphoma | 2 |
| Melanoma | 2 |
| Bile Duct Neoplasms | 1 |
| Brain Neoplasms | 1 |
| Breast Neoplasms | 1 |
| Cholangiocarcinoma | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.